NewAmsterdam Pharma (NAMS) Prepaid Assets (2021 - 2026)

NewAmsterdam Pharma has disclosed Prepaid Assets across 6 years of filings, most recently posting $2.3 million for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $2.3 million, down 74.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (down 74.28% YoY), and the FY2025 annual result was $38.1 million, up 1622.58% from the prior year.
• Prepaid Assets came in at $2.3 million for Q1 2026 at NewAmsterdam Pharma, down from $38.1 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $38.1 million in Q4 2025 to a low of $1.5 million in Q2 2025.
• The 5-year median for Prepaid Assets is $4.3 million (2023), against an average of $9.7 million.
• Across the five-year window, Prepaid Assets surged 1622.58% in 2025 and tumbled 74.28% in 2026, its largest moves.
• NewAmsterdam Pharma's Prepaid Assets stood at $7.8 million in 2022, then sank by 72.87% to $2.1 million in 2023, then advanced by 4.29% to $2.2 million in 2024, then soared by 1622.58% to $38.1 million in 2025, then plunged by 94.05% to $2.3 million in 2026.
• The last three Prepaid Assets figures came in at $2.3 million (Q1 2026), $38.1 million (Q4 2025), and $28.1 million (Q3 2025), per Business Quant data.